BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2883648)

  • 1. A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula.
    Heij HA; Bruining HA; Verschoor L
    Pancreas; 1986; 1(2):188-90. PubMed ID: 2883648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closure of a high-output external pancreatic fistula by SMS 201-995, a long-acting analogue of somatostatin.
    de Bois MH; Bosman CH; de Graaf P; van Hoogenhuijze J
    Neth J Med; 1988 Jun; 32(5-6):293-7. PubMed ID: 2899299
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of pancreatic cutaneous fistulas with a somatostatin analog.
    Prinz RA; Pickleman J; Hoffman JP
    Am J Surg; 1988 Jan; 155(1):36-42. PubMed ID: 2893556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of somatulin in the treatment of complications after operations on the pancreatic gland].
    Iareshko VG; Mikheev IuA; Krivoruchko IV
    Klin Khir; 2009 Jan; (1):23-5. PubMed ID: 19670749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term administration of SMS 201-995 in the management of an external pancreatic fistula.
    Kwan D; Aufses AH
    Am J Gastroenterol; 1989 Mar; 84(3):326-8. PubMed ID: 2919593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogues and pancreatic fistulas.
    Bassi C; Falconi M; Caldiron E; Bonora A; Salvia R; Pederzoli P
    Digestion; 1996; 57 Suppl 1():94-6. PubMed ID: 8813483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Interference with cyclosporine immunosuppression.
    Rosenberg L; Dafoe DC; Schwartz R; Campbell DA; Turcotte JG; Tsai ST; Vinik A
    Transplantation; 1987 May; 43(5):764-6. PubMed ID: 2883747
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of somatostatin or octreotide efficacy in the treatment of external pancreatic fistulas].
    Brunaud L; Sebbag H; Marchal F; Verdier A; Bresler L; Tortuyaux JM; Boissel P
    Ann Chir; 2001 Feb; 126(1):34-41. PubMed ID: 11255969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula.
    Gans SL; van Westreenen HL; Kiewiet JJ; Rauws EA; Gouma DJ; Boermeester MA
    Br J Surg; 2012 Jun; 99(6):754-60. PubMed ID: 22430616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of somatostatin in the conservative treatment of external pancreatic fistula].
    Fernández Balaguer P; Suárez Miguelez JM; Galeano Díaz F; Hernández Antequera E; Asensio Prianes L; Urquijo Tomatti H; Rodelgo Lozano M; García-Sancho Martín L
    Rev Esp Enferm Apar Dig; 1989 Sep; 76(3):222-8. PubMed ID: 2573114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995.
    Ahrén B; Tranberg KG; Bengmark S
    Br J Surg; 1988 Jul; 75(7):718. PubMed ID: 2901281
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibition of exocrine pancreatic function by somatostatin?].
    Jung D; Düben W; Lux M; Heymann H
    Z Gastroenterol; 1986 Mar; 24(3):161-2. PubMed ID: 2871669
    [No Abstract]   [Full Text] [Related]  

  • 13. [Natural history of the pancreatic stump after duodenopancreatectomy of the pancreatic head].
    Gouillat C; Faucheron JL; Balique JG; Gayet B; Saric J; Partensky C; Baulieux J; Chipponi J
    Ann Chir; 2002 Jun; 127(6):467-76. PubMed ID: 12122721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of external pancreatic fistula by depot somatostatin].
    Faroux R; Bretagne JF; Le Jean-Colin I; Loreal O; Darnault P; Gastard J
    Presse Med; 1987 Aug 29-Sep 5; 16(28):1379. PubMed ID: 2888105
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of a somatostatin analog in the treatment of an external pancreatic fistula.
    Turner JW
    Mo Med; 1994 Dec; 91(12):737-9. PubMed ID: 7854311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of octreotide in the treatment of external pancreatic pure fistulas: a single-institution prospective experience.
    Bassi C; Falconi M; Salvia R; Caldiron E; Butturini G; Pederzoli P
    Langenbecks Arch Surg; 2000 Jan; 385(1):10-3. PubMed ID: 10664113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas.
    Leandros E; Antonakis PT; Albanopoulos K; Dervenis C; Konstadoulakis MM
    Can J Gastroenterol; 2004 May; 18(5):303-6. PubMed ID: 15152279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short report: octreotide in the treatment of external pancreatic fistulas.
    Tulassay Z; Flautner L; Vadász A; Fehérvári I
    Aliment Pharmacol Ther; 1993 Jun; 7(3):323-5. PubMed ID: 8364137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites.
    Grauer L; Barkin JS
    Digestion; 1994; 55 Suppl 1():24-8. PubMed ID: 7907566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.